Budros Ruhlin & Roe Trimmed By $322,644 Its Amazon.Com (AMZN) Position; Lemaitre Vascular (LMAT) Shorts Up By 0.54%

May 26, 2018 - By Michael Collier

Amazon.com, Inc. (NASDAQ:AMZN) Logo

Budros Ruhlin & Roe Inc decreased Amazon.Com Inc (AMZN) stake by 21.28% reported in 2017Q4 SEC filing. Budros Ruhlin & Roe Inc sold 276 shares as Amazon.Com Inc (AMZN)’s stock rose 28.13%. The Budros Ruhlin & Roe Inc holds 1,021 shares with $1.19M value, down from 1,297 last quarter. Amazon.Com Inc now has $781.29B valuation. The stock increased 0.44% or $7.08 during the last trading session, reaching $1610.15. About 2.48M shares traded. Amazon.com, Inc. (NASDAQ:AMZN) has risen 76.78% since May 26, 2017 and is uptrending. It has outperformed by 65.23% the S&P500.




Lemaitre Vascular Inc (NASDAQ:LMAT) had an increase of 0.54% in short interest. LMAT’s SI was 1.01 million shares in May as released by FINRA. Its up 0.54% from 1.01 million shares previously. With 154,200 avg volume, 7 days are for Lemaitre Vascular Inc (NASDAQ:LMAT)’s short sellers to cover LMAT’s short positions. The SI to Lemaitre Vascular Inc’s float is 6.75%. The stock decreased 1.28% or $0.42 during the last trading session, reaching $32.51. About 107,408 shares traded. LeMaitre Vascular, Inc. (NASDAQ:LMAT) has risen 48.54% since May 26, 2017 and is uptrending. It has outperformed by 36.99% the S&P500.

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. The company has market cap of $627.85 million. The firm provides angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; carotid shunts to temporarily divert or shut blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and powered phlebectomy devices that enable removal of varicose veins. It has a 37.8 P/E ratio. It also offers embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude blood flow; and perfusion catheters that temporarily perfuse blood and other liquids into the vasculature.

Investors sentiment decreased to 0.91 in 2017 Q4. Its down 0.80, from 1.71 in 2017Q3. It is negative, as 24 investors sold LeMaitre Vascular, Inc. shares while 44 reduced holdings. 19 funds opened positions while 43 raised stakes. 13.74 million shares or 5.25% more from 13.06 million shares in 2017Q3 were reported. Morgan Stanley accumulated 0% or 101,139 shares. Conestoga Llc owns 1.33M shares or 1.62% of their US portfolio. Prudential Fincl Inc accumulated 0% or 26,967 shares. Fiduciary Tru owns 0.01% invested in LeMaitre Vascular, Inc. (NASDAQ:LMAT) for 14,407 shares. Principal Grp, a Iowa-based fund reported 119,849 shares. Laurion Cap Management L P holds 0% in LeMaitre Vascular, Inc. (NASDAQ:LMAT) or 15,042 shares. Envestnet Asset Management Incorporated invested in 0% or 4,493 shares. Dupont Mngmt owns 13,319 shares. 11,674 are held by Manufacturers Life Insur The. Driehaus Cap Limited Co has invested 0.14% in LeMaitre Vascular, Inc. (NASDAQ:LMAT). Tci Wealth Advisors holds 0% of its portfolio in LeMaitre Vascular, Inc. (NASDAQ:LMAT) for 34 shares. Federated Invsts Pa reported 0.01% stake. Menta Capital Limited Com owns 21,051 shares or 0.13% of their US portfolio. Needham Investment Mgmt Ltd Co holds 0.24% or 28,000 shares. 240,815 were reported by Columbia Wanger Asset Ltd Liability Corp.

Since February 26, 2018, it had 0 insider buys, and 6 insider sales for $5.18 million activity. $1.09M worth of stock was sold by LeMaitre George W on Tuesday, March 6. The insider Jasinski Lawrence J sold 1,000 shares worth $34,000.

Among 12 analysts covering LeMaitre Vascular (NASDAQ:LMAT), 6 have Buy rating, 0 Sell and 6 Hold. Therefore 50% are positive. LeMaitre Vascular had 39 analyst reports since July 29, 2015 according to SRatingsIntel. The stock has “Hold” rating by First Analysis on Friday, October 27. The firm earned “Hold” rating on Thursday, July 27 by Canaccord Genuity. The rating was maintained by Canaccord Genuity on Friday, October 27 with “Hold”. Roth Capital maintained it with “Buy” rating and $18.50 target in Tuesday, May 3 report. The firm has “Buy” rating by Stifel Nicolaus given on Friday, July 28. The firm earned “Neutral” rating on Thursday, September 22 by Sidoti. TH Capital maintained the shares of LMAT in report on Wednesday, July 29 with “Buy” rating. The stock has “Buy” rating by Canaccord Genuity on Tuesday, May 3. The rating was maintained by Stifel Nicolaus on Friday, October 27 with “Buy”. The rating was maintained by Dougherty & Company with “Buy” on Monday, December 7.

Another recent and important LeMaitre Vascular, Inc. (NASDAQ:LMAT) news was published by Globenewswire.com which published an article titled: “LeMaitre Vascular to Present at Upcoming Investor Conferences” on May 03, 2018.

Analysts await Amazon.com, Inc. (NASDAQ:AMZN) to report earnings on July, 26. They expect $2.42 earnings per share, up 505.00% or $2.02 from last year’s $0.4 per share. AMZN’s profit will be $1.17B for 166.34 P/E if the $2.42 EPS becomes a reality. After $3.27 actual earnings per share reported by Amazon.com, Inc. for the previous quarter, Wall Street now forecasts -25.99% negative EPS growth.

Investors sentiment increased to 1.29 in Q4 2017. Its up 0.03, from 1.26 in 2017Q3. It is positive, as 69 investors sold AMZN shares while 578 reduced holdings. 168 funds opened positions while 667 raised stakes. 280.02 million shares or 0.09% more from 279.77 million shares in 2017Q3 were reported. Evermay Wealth Management Ltd Liability Com invested in 2,937 shares or 1.26% of the stock. Leavell Invest Mgmt stated it has 394 shares or 0.05% of all its holdings. State Of Tennessee Treasury Department owns 338,239 shares for 1.77% of their portfolio. State Of Alaska Department Of Revenue holds 1.08% of its portfolio in Amazon.com, Inc. (NASDAQ:AMZN) for 38,857 shares. Boston Ltd Liability Co stated it has 88,319 shares or 2.23% of all its holdings. Wealthtrust Axiom Llc holds 0.1% in Amazon.com, Inc. (NASDAQ:AMZN) or 230 shares. 211 are owned by Fragasso Grp. Fukoku Mutual Life Insurance Company invested in 0.3% or 1,715 shares. Ashford Cap holds 0.28% or 1,517 shares. 6,223 are owned by Kamunting Street Capital Mgmt Lp. Great West Life Assurance Can reported 0.91% of its portfolio in Amazon.com, Inc. (NASDAQ:AMZN). Marathon Asset Mngmt Limited Liability Partnership holds 0.99% or 54,788 shares. Winslow Evans And Crocker reported 3,574 shares. Moreover, Lvw Advisors Ltd Liability Corporation has 0.22% invested in Amazon.com, Inc. (NASDAQ:AMZN). Modera Wealth Ltd reported 297 shares or 0.07% of all its holdings.

Since December 7, 2017, it had 0 insider buys, and 21 sales for $64.49 million activity. 1,985 shares were sold by Jassy Andrew R, worth $2.90M. On Thursday, February 15 Blackburn Jeffrey M sold $18.50M worth of Amazon.com, Inc. (NASDAQ:AMZN) or 12,666 shares. 544 Amazon.com, Inc. (NASDAQ:AMZN) shares with value of $795,502 were sold by Reynolds Shelley. 2,000 shares were sold by WILKE JEFFREY A, worth $2.91M. STONESIFER PATRICIA Q sold 1,375 shares worth $2.17 million. $1.01 million worth of Amazon.com, Inc. (NASDAQ:AMZN) shares were sold by ALBERG TOM A. The insider Zapolsky David sold 2,216 shares worth $3.24M.

Among 55 analysts covering Amazon.com (NASDAQ:AMZN), 52 have Buy rating, 0 Sell and 3 Hold. Therefore 95% are positive. Amazon.com had 302 analyst reports since July 21, 2015 according to SRatingsIntel. As per Friday, July 29, the company rating was maintained by Citigroup. The stock of Amazon.com, Inc. (NASDAQ:AMZN) earned “Buy” rating by Canaccord Genuity on Friday, October 28. The stock has “Buy” rating by UBS on Friday, April 29. Piper Jaffray maintained the shares of AMZN in report on Thursday, April 19 with “Buy” rating. On Monday, December 18 the stock rating was maintained by J.P. Morgan with “Buy”. Mizuho maintained Amazon.com, Inc. (NASDAQ:AMZN) on Friday, October 27 with “Buy” rating. The rating was maintained by Axiom Capital with “Buy” on Friday, July 29. Macquarie Research maintained the shares of AMZN in report on Tuesday, December 22 with “Outperform” rating. Mizuho maintained Amazon.com, Inc. (NASDAQ:AMZN) rating on Friday, September 23. Mizuho has “Buy” rating and $950 target. The stock of Amazon.com, Inc. (NASDAQ:AMZN) earned “Buy” rating by Mizuho on Tuesday, August 25.

More notable recent Amazon.com, Inc. (NASDAQ:AMZN) news were published by: Seekingalpha.com which released: “Best And Worst Performing Nasdaq 100 Stocks Of 2018” on May 25, 2018, also Seekingalpha.com with their article: “Bloomberg: Fed watching Amazon’s move into finances” published on May 24, 2018, Livetradingnews.com published: “Amazon.com, Inc. (NASDAQ:AMZN) Heffx Stock Technicals” on May 25, 2018. More interesting news about Amazon.com, Inc. (NASDAQ:AMZN) were released by: 247Wallst.com and their article: “5 Most Important Things in Business Today” published on May 25, 2018 as well as Seekingalpha.com‘s news article titled: “The Proof That Amazon Is Undervalued” with publication date: May 23, 2018.

Amazon.com, Inc. (NASDAQ:AMZN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: